Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

13-azaprostanoic acid

Known as: Cyclopentaneheptanoic acid, 2-(heptylamino)-, (1S-trans)- 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1985
1985
Studies were undertaken to examine the pharmacological properties and stereochemical requirements of a limited series of… Expand
1985
1985
The effect of the thromhoxane A2prosta-glandin H2 (TxA2PGH2) receptor antagonist trans- 712-(p-hydroxyphenethylamino)-cyclopentyl… Expand
Highly Cited
1983
Highly Cited
1983
In the present study we characterized the interaction between the thromboxane A2/prostaglandin H2 antagonist, trans-13… Expand
1983
1983
In the present study we investigated the ability of the arachidonic acid metabolites, prostaglandin H2 and thromboxane A2, to… Expand
Highly Cited
1983
Highly Cited
1983
Macrophages, neutrophils, and platelets may play a role in acute edematous lung injury, such as that seen in the adult… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
1983
1983
The effects of 13-azaprostanoic acid (13-APA) were studied during acute myocardial ischemia in cats and in rabbit sudden death… Expand
Highly Cited
1981
Highly Cited
1981
Platelets obtained from some diabetic patients show enhanced in vitro platelet aggregation. This study sought to determine… Expand
1981
1981
Platelets obtained from some diabetic patients show enhanced in vitro platelet aggregation. This study sought to determine if… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
Highly Cited
1980
Highly Cited
1980
The potential deleterious role of the proaggregatory vasoconstrictor, thromboxane A(2), in endotoxic shock was investigated in… Expand
  • figure 1
  • figure 2
  • table I
Highly Cited
1979
Highly Cited
1979
A newly synthesized 13-aza derivative of prostanoic acid (13-APA) specifically inhibited human platelet aggregation induced by… Expand